Zim Laboratories Ltd.

ZIMLAB

₹101.71

0.91% (0.92)

Market Cap

₹497 Cr.

P/E

40.83

About

Zim Laboratories Ltd has established itself as one of the preferred healthcare solution providers in the field of New Drug Delivery Systems (NDDS). The company has pioneered several innovative techn… Read more

Zim Laboratories Ltd has established itself as one of the preferred healthcare solution provi… Read more

Low

52W Range

High

128

Timeline

Key company specific updates

Company Timeline

Custom financial statementNew

Edit rows

In Rs. Cr.	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025

In Rs. Cr.	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Balance sheet
Net Block	92.19	88.75	94.16	106	116	107	106	109	161	164
Shareholders Funds	98.96	118	137	151	154	161	176	200	239	252
Profit & Loss
Operating Profit	29.20	31.49	34.78	42.03	22.61	39.76	40.98	51.99	41.33	43.73
Net Sales	269	235	273	335	278	307	333	399	367	379
Cash flow
Cash from Operating Activity	21.94	32.07	36.68	34.94	21.92	31.85	49.21	38.17	16.28	41.15
Net Capex (est)	13.11	8.52	28.49	20.30	18.54	6.47	15.07	36.65	73.38	40.07
Ratios
ROCE (%)	18.21	20.50	18.55	19.07	7.21	14.60	15.00	17.73	10.64	9.62
ROE (%)	5.15	15.71	13.99	10.15	2.14	4.55	8.28	12.20	7.22	4.82

Forensics

8 Yes

Positive for this company

1 Neutral

Neutral for this company

8 No

Negative for this company

0 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Depreciation Effect

Depreciation accounting is not leading to increase in profits
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Retail Holding

Retail has been selling the stock which is usually a good time to buy
Promoter Holding

Promoter has not sold any shares in the last 90 days
Revenue Recognition

Chances of aggressive revenue recognition - operating profit of company is not getting converted to cash and recievables rising faster than sales

Price & Performance

ROE

Net profit margin is responsible for roe increase over last 10 years
Debt

Company should not have issues servicing its debt
Balance Sheet Strength

Balance sheet of the company is strong. it shouldnt have solvency or liquidity issues
Capex vs ROCE

Roce of the company has decreased even without significant capex
Current vs Historic Valuation

Company is trading at a premium to 3yr historic valuations
Share price

Share price has increased over last 10 years but more due to rerating
Working Capital

Company has significant working capital which is dragging its roce and roe
Sales Growth

Sales of the company has grown at a slow pace
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Customer Segment

Capex

Asset Break-Up

Operational Metrics

R&D as a % of Total Sales (%)

Zim Laboratories Ltd.

R&D as a % of Total Sales (%)
Source

Peer Comparison

Peer Name	Latest Price	PE	Market cap(Cr)	Prom Holding(%)	YoY Qtly Sales(%)	ROCE (%)	ROE (%)
Zim Laboratories	102.16	40.37	491	33.26	-7.75	9.62	4.82
Albert David	831.8	26.73	460	62.24	-15.91	24.49	19.69
Ind-Swift Lab.	94.93	2.33	560	40.94	-96.99	27	45.19
Lyka Labs	115.79	51.83	415	58.16	20.39	3.67	-3.65
Venus Remedies	439.2	12.57	570	41.76	-0.1	8.17	5.84
Medico Remedies	50.46	40.51	409	63.79	-0.05	22.67	15.83
Jenburkt Pharma	1,270	17.95	575	46.68	5.68	23.96	17.92
Medicamen Biotech	422.15	80.94	575	43.16	-37.42	9.04	4.59

Corporate Actions

Consolidated BonusDividend

DATE

DETAILS

2022, Dec 22

Bonus 2 bonus shares for every 1 held. Bonus shares should be credited within 3 days after the ex-date.

2019, Sep 19

Dividend Dividend of Rs.0.5 per share

2018, Oct 04

Bonus 1 bonus shares for every 1 held. Bonus shares should be credited within 3 days after the ex-date.

2018, Sep 03

Dividend Dividend of Rs.1 per share

Customers

Gufic Biosciences Ltd.
RPG Life Sciences Ltd.
Sun Pharmaceutical Industries Ltd.
Alkem Laboratories Ltd.
Mankind Pharma

FAQs on Zim Laboratories Ltd. Business

What does Zim Laboratories do?

Zim Laboratories Ltd is a leading healthcare solution provider specializing in New Drug Delivery Systems. They have developed innovative technologies and products in areas such as Pellets, Multiplets, Resinates, Herbals, and Diagnostics.

Who are the competitors of Zim Laboratories?

Zim Laboratories major competitors are Albert David, Ind-Swift Lab., Lyka Labs, Venus Remedies, Medico Remedies, Jenburkt Pharma, Medicamen Biotech.
Market Cap of Zim Laboratories is ₹491 Crs.
While the median market cap of its peers are ₹560 Crs.

Is Zim Laboratories financially stable compared to its competitors?

Zim Laboratories seems to be less financially stable compared to its competitors.
Altman Z score of Zim Laboratories is 3.03 and is ranked 8 out of its 8 competitors.

View FAQ's On Shareprice

Cash Flow Machines

Actual Cash profits are more important than accounting profits. List of companies spitting out cash profits

Run Query

Global Leaders

Companies with a dominant global position in a product. Might be a sign of very strong moat.

Run Query

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release							Mar Jun Sep Dec	Mar Jun Dec	Mar Jun Sep Dec	Jun Sep Dec
Investor Presentation	May	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Dec	Dec	Feb	Jun Sep Dec
Conference Call	May	Mar Sep	Mar Jun Sep Dec
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Zim Laboratories Ltd.

Zim Laboratories - A very under-researched but very impressive Small Cap Pharma Company - Mohit Jangir

Pharmaceutical Sector

How The Pharma Industry Works - PPFAS

Deep Dive into Pharma Sector - Omkara Capital

Pharma Compliance In-Depth - Amit Rajan

Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar

Nutraceuticals- Industry Overview - Value Educator

Generic Opportunity for Indian Pharma Companies - Anish Moonka

Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Zim Laboratories Ltd.

Zim Laboratories Ltd.

About

Timeline

Company Timeline

8 Yes

1 Neutral

8 No

0 No Data

Accounting & Shareholding

Contingent Liabilities

Depreciation Effect

Other Income

Pledge

Retail Holding

Promoter Holding

Revenue Recognition

Price & Performance

ROE

Debt

Balance Sheet Strength

Capex vs ROCE

Current vs Historic Valuation

Share price

Working Capital

Sales Growth

Margin Stability

ROCE Strength

Product Wise Break-Up

UNLOCK PREMIUM

Location Wise Break-Up

UNLOCK PREMIUM

Customer Segment

UNLOCK PREMIUM

Capex

UNLOCK PREMIUM

Asset Break-Up

UNLOCK PREMIUM

R&D as a % of Total Sales (%)

R&D as a % of Total Sales (%)

What does Zim Laboratories do?

Who are the competitors of Zim Laboratories?

Is Zim Laboratories financially stable compared to its competitors?

SIGN UP FOR FREE